Spyre Therapeutics, Inc. (SYRE)
33.50
+0.44
(+1.33%)
USD |
NASDAQ |
Dec 18, 16:00
33.50
0.00 (0.00%)
After-Hours: 18:23
Spyre Therapeutics Gross Profit (Annual): 0.00 for Dec. 31, 2024
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| PTC Therapeutics, Inc. | 688.64M |
| NovaBay Pharmaceuticals, Inc. | 6.481M |
| Palatin Technologies, Inc. | -0.2589M |
| Theriva Biologics, Inc. | -0.137M |
| Oragenics, Inc. | 0.00 |